What Is a Noise Eliminator? Interference in Immunoassays

What Is a Noise Eliminator?

A noise eliminator is a ready-to-use formulation additive that neutralizes the molecular interferences carried by biological samples, heterophilic antibodies (HA), human anti-mouse antibodies (HAMA), rheumatoid factor (RF), non-specific binding, cross-reactions, and matrix effects, so these substances can no longer distort the assay signal. Unlike a plain diluent, which only lowers the concentration of interferents, a noise eliminator actively binds or sequesters them.

The term "noise" here does not mean optical or instrumental noise. It means immunological noise: binding events that look like specific analyte detection but are actually caused by sample components bridging or blocking the assay's antibodies. The result is a plausible-looking number that is simply wrong, which is why interference is more dangerous than an obvious error.

It helps to be precise about what a noise eliminator is not. It is not a blocking buffer, which saturates unoccupied sites on the plate surface. It is not a protein stabilizer, which preserves reagent activity over time. And it is not an ordinary sample diluent, whose only anti-interference mechanism is dilution. A noise eliminator works on the sample side: it is mixed with the specimen before the assay runs, and its job is to disarm the interferents in the sample itself.

The Interference Problem in Immunoassays

Interfering substances are not rare exceptions; they are a routine feature of human samples. Prevalence estimates for anti-animal antibodies in the general population vary widely, from under 1% to as high as 80%, depending on the assay and the population studied [1]. The formats most exposed are sandwich assays, competitive assays, and IgM-capture assays: any design in which a specimen's own immunoglobulins can reach the same binding sites as the assay's antibodies.

The failure mode depends on the format. In a sandwich assay, an interferent that binds both the capture and the detection antibody can bridge them in the absence of analyte, a false positive. In a competitive assay, an interferent that occupies the analyte-binding site can block labeled analyte from binding, a false negative. Either way, the curve looks valid and the result is reported.

Heterophilic Antibodies (HA)

Heterophilic antibodies are endogenous human antibodies that bind immunoglobulins from other species. Their prevalence in the general population is estimated at 2–8% and rising. Because most immunoassays use mouse, goat, or rabbit antibodies, a heterophilic antibody can bridge capture and detection reagents directly, generating a false-positive signal proportional only to the interferent's concentration.

HAMA and HAAA

HAMA (Human Anti-Mouse Antibody) is the subtype directed specifically against mouse immunoglobulins, common in patients exposed to murine monoclonal antibody therapy, where reported prevalence reaches as high as 80% [2]. HAAA (Human Anti-Animal Antibody) is the broader category covering antibodies against immunoglobulins from any species used in the assay. Both act by the same bridging mechanism as heterophilic antibodies.

Rheumatoid Factor (RF)

Rheumatoid factor is an IgM autoantibody that binds the Fc region of IgG. Present in 1–5% of the general population and far more common in patients with autoimmune conditions, RF cross-links capture and detection antibodies in sandwich formats and produces the same false-positive pattern.

Non-Specific Binding, Cross-Reactions, and Matrix Effects

Beyond antibody-mediated interference, three related phenomena degrade result quality: non-specific binding (NSB) of sample proteins to the solid phase, cross-reactions between structurally similar molecules and the assay antibodies, and matrix effects in which sample components alter binding kinetics. NSB is covered in detail in our guide to non-specific binding. Durastab's Noise Eliminator Plus is formulated against all six classes together: HA, HAMA, RF, NSB, cross-reaction, and matrix effect.

How a Noise Eliminator Works

Noise eliminators combine two complementary mechanisms. On the sample side, the ready-to-use formulation is mixed directly with serum or plasma; its blocking components bind or sequester heterophilic antibodies, HAMA, and RF before they can reach the assay's antibodies, while the dilution itself lowers the effective concentration of every matrix component. On the reagent side, dedicated blocker products are added to the conjugate or reagent formulation instead of to the sample.

Reagent-side blockers work in two ways. Active blockers have high affinity for the interfering antibodies themselves: they bind HA, HAMA, or RF and neutralize them through steric hindrance, so the interferent can no longer engage the capture or detection antibody. Passive blockers are present at high concentration as excess alternative binding sites: the interferent binds the blocker instead of the assay's antibodies, and is harmlessly washed out.

The measurable outcome is not a bigger signal — it is a truer one. A well-matched noise eliminator lowers blank readings, restores dilution linearity and spike recovery, and improves the agreement rate between assay results and the patient's clinical status. Because the analyte itself is not displaced, results move only where interference previously moved them.

Durastab Noise Eliminators and Blockers

Durastab's interference-control line covers both sides of the assay: four ready-to-use Noise Eliminator formulations for the sample side, and the HBR active/passive blocker series for the reagent side. All four noise eliminators dilute serum or plasma samples, eliminate HA, HAMA and RF interference, reduce cross-reactions and matrix effects, and prevent high background and false-positive or false-negative results. They also serve as diluents for other samples, antibodies, and labeled enzymes.

Usage is identical across the four: bring the ready-to-use reagent to reaction temperature, shake well, and mix with the sample at the recommended ratio, treating standards, calibrators, and controls at the same ratio so the matrix is matched on both sides of the curve. Applications span ELISA and chemiluminescence (sample or detection-antibody dilution), Western blot, microarray, and IHC (antibody dilution), lateral chromatography, Luminex, and microfluidics (sample dilution).

For interference that must be controlled inside the kit rather than in the patient sample, the Durastab HBR series (Active/Passive Blockers) is added directly to the formulation: 5–100 μg/mL in CLIA/ELISA enzyme conjugates, 0.2–0.4 mg/mL for LFIA sample-pad treatment, or 0.5–1.0% (v/v) in clinical-chemistry R1 reagents. Variants are selected by assay methodology and reaction system: HBR-157 through HBR-361 cover mouse, goat, and rabbit systems and can also serve clinical chemistry.

Sample Side or Reagent Side? How to Choose

• Interference comes from patient samples (variable, unpredictable, sample-dependent) → use a Noise Eliminator as the sample diluent: NEPL at 5:1 for the broadest six-class coverage, or NEPF/NEPB/NETR at 2:1 matched to your buffer and protein constraints.

• Interference must be controlled inside the kit (production of CLIA reagents, LFIA strips, clinical-chemistry R1) → add the appropriate HBR active or passive blocker to the conjugate, sample pad, or reagent at the stated working range.

• The formulation must be animal-protein-free → NEPF is the only protein-free version of the four.

• High background dominates more than false results → combine the noise eliminator with a stronger plate blocker; surface non-specific binding is a blocking-buffer problem, not a sample problem (see our NSB guide).

• You only need to bring samples into range → an ordinary sample diluent such as Sample Diluent PBS or Sample Diluent TRIS is sufficient. A conventional diluent is a buffer with a carrier protein: it reduces interference only by dilution, and does not neutralize heterophilic antibodies, RF, or matrix components. When unexplained false positives or non-linear dilution appear, dilution alone is not the answer; that is the noise eliminator's job.

A practical test separates the two needs: dilute the suspect sample twofold and re-read. If the abnormal result moves proportionally, dilution helps; if it stays wrong, an interferent is actively binding your reagents, and a neutralizing formulation is required. For the full symptom-by-symptom view of assay failures, see our checklist of 12 common ELISA errors.

Frequently Asked Questions

What does a noise eliminator do in an immunoassay?

It neutralizes interference carried by the sample (heterophilic antibodies, HAMA, rheumatoid factor, non-specific binding, cross-reactions, and matrix effects) before those components can bind the assay's antibodies. The result is fewer false positives and false negatives and better agreement with clinical status.

What is the difference between a noise eliminator and a sample diluent?

A conventional sample diluent (buffer plus carrier protein) only reduces the concentration of interferents through dilution. A noise eliminator dilutes the sample and actively binds or blocks the interfering molecules, so they cannot engage the capture or detection antibodies even at residual concentration.

How is a noise eliminator used for sample dilution?

Ready to use: warm to reaction temperature, shake well, and mix with serum or plasma at the recommended ratio: NEPL : sample = 5:1 (v/v) or higher, NEPF/NEPB/NETR = 2:1 or higher. Treat standards, calibrators, and controls at the same ratio so the matrix is matched on both sides of the curve.

Can a noise eliminator fix both false positives and false negatives?

Yes — both failure modes trace to the same interferents. Bridging of capture and detection antibodies produces false positives in sandwich formats; occupation of analyte-binding sites produces false negatives in competitive formats. Neutralizing the interferent addresses both. Confirm with dilution linearity and spike-recovery testing after the change.

Which Durastab noise eliminator should I choose?

Start from the target list and the buffer: NEPL for the broadest six-class coverage at 5:1; NEPF when the formulation must be protein-free; NEPB for phosphate-buffered systems; NETR for Tris-based systems. If interference must be controlled in the kit formulation itself rather than in the patient sample, use the HBR active/passive blocker series instead.

Do heterophilic antibodies affect all assay formats?

Any format that uses non-human immunoglobulins is exposed, but sandwich, competitive, and IgM-capture methods are the most susceptible because their readouts depend on a single bridging or competition event. Homogeneous formats with small-molecule labels are generally less affected.

References

1. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45(7):942–956. doi:10.1093/clinchem/45.7.942

2. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004;25(2):105–120. PMID 18458713.